GlucoTrack Drops 24% Despite Successful First-in-Human Study Of CGM
GlucoTrack, Inc. (GCTK) is down by 24.56 percent during Tuesday trading despite announcing the successful completion of a ...
Healio22d
Although superior to other insulin therapies, hybrid closed-loop systems differ in efficacy
The primary endpoint of the analysis was TIR, with the comparators grouped as subcutaneous insulin therapy without continuous glucose monitoring (SIT); subcutaneous insulin therapy with continuous ...